Anti-NMDAR encephalitis: A single-center, longitudinal study in China

Conclusions
Patients in China present with psychosis and seizure frequently but have a low percentage of underlying neoplasms. Re-enforced first-line immunotherapy is effective in managing anti-NMDAR encephalitis in the acute phase. Although relapse is relatively common, with combined first-line and long-term immunotherapy, most patients reached favorable outcomes.

Source: Neurology Neuroimmunology and Neuroinflammation - October 15, 2019 Category: Neurology Authors: Xu, X., Lu, Q., Huang, Y., Fan, S., Zhou, L., Yuan, J., Yang, X., Ren, H., Sun, D., Dai, Y., Zhu, H., Jiang, Y., Zhu, Y., Peng, B., Cui, L., Guan, H. Tags: Autoimmune diseases, All Clinical Neurology Article Source Type: research